Malignant Urinary Tract Neoplasm — Trials

Malignant Urinary Tract Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,955 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 507
Recruiting: 271
Ph III recruiting: 36
Growth YoY: +23.2%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (246)

clinicaltrialsPublishedShowing 651–666 of 666 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05943379	RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects	recruiting	Phase 2	85	RemeGen Co., Ltd.INDUSTRY	1	Jul 13, 2023	clinicaltrials
NCT04617756	Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract(iNDUCT)	recruiting	Phase 2	50	Centre Hospitalier Universitaire de NīmesOTHER	1	May 30, 2023